SBC Medical Group Holdings Incorporated
SBC
$4.35
-$0.01-0.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -15.48% | -20.10% | -13.49% | -3.65% | 6.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.48% | -20.10% | -13.49% | -3.65% | 6.13% |
| Cost of Revenue | -6.16% | -20.01% | -29.80% | -23.56% | -12.22% |
| Gross Profit | -18.43% | -20.13% | -7.03% | 4.02% | 13.65% |
| SG&A Expenses | -16.03% | -39.52% | -9.22% | -17.30% | -19.06% |
| Depreciation & Amortization | -- | -114.05% | -123.97% | -152.37% | -- |
| Other Operating Expenses | 57.45% | 243.03% | 273.72% | 210.57% | 203.02% |
| Total Operating Expenses | -11.60% | -22.22% | -4.89% | -7.05% | -2.30% |
| Operating Income | -20.94% | -16.93% | -24.43% | 1.26% | 20.81% |
| Income Before Tax | 11.72% | -23.53% | -35.14% | -12.20% | -0.17% |
| Income Tax Expenses | 15.90% | -28.27% | -21.57% | -24.83% | -23.57% |
| Earnings from Continuing Operations | 9.33% | -20.34% | -44.10% | -2.87% | 21.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 21.53% | -74.78% | -94.62% | -105.90% | -109.35% |
| Net Income | 9.38% | -20.39% | -44.39% | -5.31% | 18.40% |
| EBIT | -20.94% | -16.93% | -24.43% | 1.26% | 20.81% |
| EBITDA | -21.30% | -18.57% | -26.95% | -6.35% | 7.54% |
| EPS Basic | 1.33% | -27.19% | -48.88% | -72.07% | -69.13% |
| Normalized Basic EPS | -19.56% | -35.90% | -43.48% | -73.13% | -69.95% |
| EPS Diluted | 1.33% | -27.19% | -48.88% | -72.07% | -69.13% |
| Normalized Diluted EPS | -19.56% | -35.90% | -43.48% | -73.13% | -69.95% |
| Average Basic Shares Outstanding | 6.67% | 9.14% | 7.40% | 36.07% | 96.72% |
| Average Diluted Shares Outstanding | 6.67% | 9.14% | 7.40% | 36.07% | 96.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |